0
0
1/8/24 at 11:26pm
Organization
The Washington Post
Author
Teddy Amenabar
36 words
0
Comments
Older adults and those who don’t have an immune response against covid-19 will benefit the most from Paxlovid, experts say.
You are the first to view
https://www.washingtonpost.com/wellness/2024/01/08/paxlovid-antiviral-covid-rebound/
Create an account
or login to join the discussion